Phase 3
๐ Investigational Drug / Biologic
NCT06548360
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
๐ University of Alabama At Birmingham-School of Medicine โ Birmingham, Alabama
View Study & Screener โ